Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia-Reference-Cited by-同舟云学术

Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia

Published:2017-01-13 Issue:3 Volume:98 Page:280-288
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Porter John B.¹,Elalfy Mohsen²,Taher Ali³,Aydinok Yesim⁴,Lee Szu-Hee⁵,Sutcharitchan Pranee⁶,El-Ali Ali⁷,Han Jackie⁸,El-Beshlawy Amal⁹

Affiliation:

1. Department of Haematology; University College London; London UK

2. Thalassemia Center; Children's Hospital; Ain Shams University; Cairo Egypt

3. Department of Internal Medicine; American University of Beirut; Beirut Lebanon

4. Department of Pediatric Hematology; Ege University Hospital; Izmir Turkey

5. Department of Haematology; St George Hospital; Sydney NSW Australia

6. Division of Haematology; Department of Medicine; Faculty of Medicine; Chulalongkorn University and King Chulalongkorn Memorial Hospital; Bangkok Thailand

7. Novartis Pharma AG; Basel Switzerland

8. Novartis Pharmaceuticals; East Hanover NJ USA

9. Hematology Department; Pediatric Hospital; Cairo University; Cairo Egypt

Funder

Novartis Pharma

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12830/fullpdf